264 related articles for article (PubMed ID: 29603074)
1. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.
Malfará M; Pernassi M; Aragon D; Carlotti A
Int J Clin Pharm; 2018 Jun; 40(3):513-519. PubMed ID: 29603074
[TBL] [Abstract][Full Text] [Related]
2. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
3. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
[TBL] [Abstract][Full Text] [Related]
4. Risk and pharmacoeconomic analyses of the injectable medication process in the paediatric and neonatal intensive care units.
De Giorgi I; Fonzo-Christe C; Cingria L; Caredda B; Meyer V; Pfister RE; Bonnabry P
Int J Qual Health Care; 2010 Jun; 22(3):170-8. PubMed ID: 20382659
[TBL] [Abstract][Full Text] [Related]
5. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B
Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
Chen PZ; Wu CC; Huang CF
J Oncol Pharm Pract; 2020 Jun; 26(4):866-872. PubMed ID: 31566112
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and economic impact of the pharmacy resident incorporation into the healthcare team].
Arroyo Conde C; Aquerreta I; Ortega Eslava A; Goñi Zamarbide O; Giráldez Deiró J
Farm Hosp; 2006; 30(5):284-90. PubMed ID: 17166062
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of clinical pharmacist interventions in paediatric hospital patients.
Drovandi A; Robertson K; Tucker M; Robinson N; Perks S; Kairuz T
Eur J Pediatr; 2018 Aug; 177(8):1139-1148. PubMed ID: 29915870
[TBL] [Abstract][Full Text] [Related]
10. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
[TBL] [Abstract][Full Text] [Related]
11. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
Kopp BJ; Mrsan M; Erstad BL; Duby JJ
Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases.
Ali MAS; Khedr EMH; Ahmed FAH; Mohamed NNE
Int J Clin Pharm; 2018 Oct; 40(5):1257-1264. PubMed ID: 29922968
[TBL] [Abstract][Full Text] [Related]
13. Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units.
Okumura LM; Silva DM; Comarella L
Rev Paul Pediatr; 2016 Dec; 34(4):397-402. PubMed ID: 27578187
[TBL] [Abstract][Full Text] [Related]
14. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
Kjeldby C; Bjerre A; Refsum N
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
[TBL] [Abstract][Full Text] [Related]
15. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
Chen CC; Hsiao FY; Shen LJ; Wu CC
Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
[TBL] [Abstract][Full Text] [Related]
16. Cost Associated With Pediatric Delirium in the ICU.
Traube C; Mauer EA; Gerber LM; Kaur S; Joyce C; Kerson A; Carlo C; Notterman D; Worgall S; Silver G; Greenwald BM
Crit Care Med; 2016 Dec; 44(12):e1175-e1179. PubMed ID: 27518377
[TBL] [Abstract][Full Text] [Related]
17. Impact of medication therapy management on pharmacotherapy safety in an intensive care unit.
Martins RR; Silva LT; Lopes FM
Int J Clin Pharm; 2019 Feb; 41(1):179-188. PubMed ID: 30552623
[TBL] [Abstract][Full Text] [Related]
18. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
19. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
